Monopril and Teveten drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Monopril (fosinopril sodium) and Teveten (eprosartan mesylate). Common drug interactions include renal failure among females.

The phase IV clinical study analyzes what interactions people have when they take Monopril and Teveten. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Monopril?

Monopril has active ingredients of fosinopril sodium. It is often used in high blood pressure. eHealthMe is studying from 5,910 Monopril users. Check the latest studies of Monopril.

What is Teveten?

Teveten has active ingredients of eprosartan mesylate. It is often used in high blood pressure. eHealthMe is studying from 1,482 Teveten users. Check the latest studies of Teveten.

On Jul, 19, 2026

11 people who take Monopril and Teveten together, and have interactions are studied.

What are the common drug interactions of Monopril and Teveten, by gender? *:

female:

Renal failure (kidney dysfunction)
Cardiopulmonary failure (cessation of normal circulation of the blood due to failure of the heart to contract)
Maternal exposure during pregnancy (use of substance during pregnancy)
Foetal growth retardation (a baby in the womb fails to grow at the expected rate during the pregnancy)
Pregnancy
Acute respiratory failure
Cardiovascular insufficiency (inadequate functioning of heart)
Drug exposure during pregnancy
Gastric bypass
Nephrolithiasis (calculi in the kidneys)

male:

n/a

What are the common drug interactions of Monopril and Teveten, by age (0-1 to 60+)? *:

0-1:

Cardiopulmonary failure (cessation of normal circulation of the blood due to failure of the heart to contract)
Hypotonia (low muscle tone)
Limb malformation (abnormal birth defect of leg)
Renal failure (kidney dysfunction)
Foetal growth retardation (a baby in the womb fails to grow at the expected rate during the pregnancy)
Foetal growth restriction (poor growth of a baby while in the mother's womb during pregnancy)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Live birth
Maternal exposure during pregnancy (use of substance during pregnancy)
Oligohydramnios (a condition in pregnancy characterized by a deficiency of amniotic fluid)
Gastric bypass

40-49:

Cardiopulmonary failure (cessation of normal circulation of the blood due to failure of the heart to contract)
Foetal distress syndrome (altered heart rate or rhythm and leading tocompromised blood flow or changes in blood chemistry of foetus)
Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
Foetal growth restriction (poor growth of a baby while in the mother's womb during pregnancy)
Hypotonia (low muscle tone)
Limb malformation (abnormal birth defect of leg)
Low birth weight baby
Renal failure (kidney dysfunction)
Nephrolithiasis (calculi in the kidneys)
Neutropenic colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition)

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Type 2 Diabetes: 3 people, 27.27%
Drug Exposure During Pregnancy: 2 people, 18.18%
Neutropenic Colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition): 1 person, 9.09%
Kidney Stones: 1 person, 9.09%
Enterococcal Bacteraemia (presence of bacteria lactic acid in the blood): 1 person, 9.09%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Monopril and Teveten?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously